<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The receptor for the gene product of the <z:hpo ids='HP_0001513'>obesity</z:hpo> gene, leptin, was recently reported to be expressed on murine and human hematopoietic progenitor cells </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we studied the expression of the leptin receptor, OB-R, in <z:mpath ids='MPATH_458'>normal</z:mpath> myeloid precursors, human <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines, and primary leukemic cells using reverse-transcriptase polymerase chain reaction </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoiesis, OB-R was expressed in CD34(+) cells </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> promyelocytes (CD34(-)33(+) and CD34(-)13(+)) expressed only very low levels of the short, presumably nonsignaling isoform </plain></SENT>
<SENT sid="4" pm="."><plain>Both the long and short isoforms of OB-R were expressed in 10 of 22 samples from patients with newly diagnosed primary or secondary <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), with a higher incidence of the long isoform in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (87.6% v 28.6%; P =.01) </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of OB-R expression was higher in recurrent than in newly diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (P &lt;.001), and samples from four patients with refractory <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> showed strong expression of both isoforms </plain></SENT>
<SENT sid="6" pm="."><plain>Both OB-R isoforms were also expressed in newly diagnosed and recurrent <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> cells but were essentially absent in samples of <z:hpo ids='HP_0011010'>chronic</z:hpo> or <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In vitro growth of myeloid leukemic cell lines and of blasts from 14 primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMLs</z:e> demonstrated that recombinant human leptin alone induced low level proliferation, significantly (P &lt;.05) increased proliferation induced by recombinant human granulocyte colony-stimulating factor, interleukin 3, and stem cell factor in a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and increased colony formation (P &lt;.005) </plain></SENT>
<SENT sid="8" pm="."><plain>Also, leptin <z:mp ids='MP_0006043'>reduced apoptosis</z:mp> induced by cytokine withdrawal in MO7E and TF-1 cells </plain></SENT>
<SENT sid="9" pm="."><plain>Serum leptin levels correlated only with body mass index (P &lt; </plain></SENT>
<SENT sid="10" pm="."><plain>001) and gender (P =.03) </plain></SENT>
<SENT sid="11" pm="."><plain>Results confirm the reported expression of leptin receptor in <z:mpath ids='MPATH_458'>normal</z:mpath> CD34(+) cells and demonstrate the frequent expression of leptin receptors in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> blasts </plain></SENT>
<SENT sid="12" pm="."><plain>While <z:mpath ids='MPATH_458'>normal</z:mpath> promyelocytes lack receptor expression, leukemic promyelocytes express both isoforms </plain></SENT>
<SENT sid="13" pm="."><plain>We also demonstrate proliferative effects of leptin alone and in combination with other physiologic cytokines, and anti-apoptotic properties of leptin </plain></SENT>
<SENT sid="14" pm="."><plain>These findings could have implications for the pathophysiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>